Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
HAMPTON, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 9:00 a.m. ET.
Related news for (CLDX)
- Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
- Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025
- Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- celldex therapeutics presents landmark 52 week results from barzolvolimab phase 2 study in chronic spontaneous urticaria at eadv 2024